Skip to main content

From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 3 November

Jessica Amir
November 3, 2020

Morning Bell 2 November

Jessica Amir
November 2, 2020

Weekly Wrap 30 October

Jessica Amir
October 30, 2020

Morning Bell 30 October

Jessica Amir
October 30, 2020

Morning Bell 29 October

Jessica Amir
October 29, 2020

Morning Bell 28 October

Jessica Amir
October 28, 2020

Morning Bell 27 October

Jessica Amir
October 27, 2020

Morning Bell 26 October

Jessica Amir
October 26, 2020

Weekly Wrap 23 October

Jessica Amir
October 23, 2020

Morning Bell 23 October

Jessica Amir
October 23, 2020

Morning Bell 22 October

Jessica Amir
October 22, 2020

Morning Bell 21 October

Jessica Amir
October 21, 2020